LIAONING CHENGDA BIOTECHNOLOGY CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.81 CNY | -0.24% |
|
+1.87% | -11.38% |
| Apr. 29 | Liaoning Chengda Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 24 | Tech Sector Galvanizes Asian Stock Markets | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 2.05B 284M | Sales 2025 * | 2.51B 348M | Capitalization | 11.89B 1.65B |
|---|---|---|---|---|---|
| Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 5.79 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.73 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 1,732 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 40.37% |
More Fundamentals
* Assessed data
More news
More news
| 1 day | -0.24% | ||
| 1 week | +1.87% | ||
| Current month | +1.87% | ||
| 1 month | +3.93% | ||
| 3 months | -3.65% | ||
| 6 months | -14.49% | ||
| Current year | -11.38% |
1 week
28.53
29.08
1 month
26.6029.08
Current year
24.6132.65
1 year
24.6135.71
3 years
24.6189.99
5 years
24.6189.99
10 years
24.6189.99
| Managers | Title | Age | Since |
|---|---|---|---|
Yu Mao
CEO | Chief Executive Officer | 44 | 07-06-30 |
Jian Wei Cui
DFI | Director of Finance/CFO | 46 | 22-01-25 |
Wei Qiang Sun
CTO | Chief Tech/Sci/R&D Officer | 64 | 18-08-02 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ning Li
CHM | Chairman | 55 | 05-12-31 |
Xiao Hui Liu
BRD | Director/Board Member | 55 | 20-02-29 |
Jun Wei Yang
BRD | Director/Board Member | 49 | 02-06-30 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 0 M€ | +3.45% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-08 | 28.81 | -0.24% | 1,218,186 |
| 24-05-07 | 28.88 | +0.03% | 1,196,349 |
| 24-05-06 | 28.87 | +2.09% | 2,011,265 |
| 24-04-30 | 28.28 | -1.08% | 1,619,054 |
End-of-day quote Shanghai S.E., May 07, 2024
More quotes
Liaoning Chengda Biotechnology Co Ltd is a China-based company mainly engaged in the research, production, and sales of human vaccines. The Company's main products include rabies vaccine for human use, freeze-dried rabies vaccine for human use, inactivated Japanese encephalitis vaccine for human use and freeze-dried encephalitis inactivated vaccine. The Company's products include two brands: Chengda Suda and Chengda Libao.
Sector
Pharmaceuticals
Calendar
2024-08-20
- Q2 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
28.81
CNY
Average target price
40
CNY
Spread / Average Target
+38.84%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -11.38% | 1.65B | |
| -3.35% | 88.91B | |
| +4.08% | 41.25B | |
| -15.09% | 31.99B | |
| +51.84% | 24.73B | |
| -15.13% | 15.54B | |
| -8.63% | 12.05B | |
| -40.39% | 12.07B | |
| +6.22% | 8.84B | |
| -5.15% | 8.3B |
- Stock Market
- Equities
- 688739 Stock